Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis
Brett W. Sperry, Mazen Hanna, Sanjiv J. Shah, Wael A. Jaber, John A. Spertus
Topics & Concepts
MedicineSpironolactoneInternal medicineCardiologyCardiac amyloidosisHeart failureClinical endpointCohortPopulationEjection fractionHeart failure with preserved ejection fractionRandomized controlled trialEnvironmental healthAmyloidosis: Diagnosis, Treatment, OutcomesHeart Failure Treatment and ManagementHormonal Regulation and Hypertension